Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2022-10-05 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Positive WHO data received for VISITECT® CD4 test
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Omega Diagnostics Group PLC regarding the receipt of a draft performance evaluation report from the WHO for their VISITECT CD4 test. It is a corporate news update concerning operational milestones and potential financial implications (deferred consideration), rather than a formal financial report, proxy statement, or governance document. As it is a general regulatory announcement that does not fit into more specific categories like M&A or Earnings Release, it is classified as an RNS.
2022-10-05 English
Posting of Annual Report and confirmation of AGM
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from Omega Diagnostics Group PLC via the RNS (Regulatory News Service). It explicitly states that the Annual Report and Accounts and the Notice of AGM have been posted to shareholders and provides a link to where they can be accessed. Per the 'Menu vs Meal' rule, this is an announcement of the publication of reports, not the reports themselves, making it a Report Publication Announcement (RPA).
2022-09-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing changes in significant share ownership. It explicitly details the acquisition or disposal of voting rights by IG Markets Limited in Omega Diagnostics Group PLC, crossing specific thresholds. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2022-09-20 English
Purchase of Shares by Directors
Director's Dealing Classification · 1% confidence The document is an official notification of share purchases by company directors (Simon Douglas, Jag Grewal, and Chris Lea). It explicitly uses the terminology 'Purchase of Shares by Directors' and includes the standard regulatory disclosure tables for 'transactions of persons discharging managerial responsibilities' (PDMRs). This aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2022-09-16 English
Investor presentation and Confirmation of AGM
AGM Information Classification · 1% confidence The document is a short announcement (under 5,000 characters) issued via RNS (Regulatory News Service) that provides information about an upcoming investor presentation and confirms the date and location of the Annual General Meeting (AGM). It does not contain the actual presentation slides or the full AGM materials, but rather serves as a notification of these events. Therefore, it falls under the category of a regulatory announcement/filing.
2022-09-13 English
Final Results
Earnings Release Classification · 1% confidence The document is titled 'Preliminary Results' for Omega Diagnostics Group PLC for the year ended 31 March 2022. It contains financial highlights, operational highlights, a Chairman's statement, and a Chief Executive's review. This is a standard format for an initial announcement of annual financial results, which precedes the full audited Annual Report. According to the filing definitions, this is classified as an Earnings Release (ER). FY 2022
2022-09-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.